Sireesh Appajosyula bought $91k of CNTN
Chief Executive Officer at Tharimmune, Inc.. 61,496 shares at an average of $1.48, traded Jun 20, 2025, filed Jun 23, 2025.
Score components
- +25RoleCEO
- +9Trade size$91k at market
- +10Relative to holdingsHoldings up 1824%
- +8Price context61% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +26.7%, 3m +122.1%, 6m +90.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001641172-25-016168, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 20, 2025 | POpen-market purchase Common Stock | +60,806 | $1.48 | $90k | 64,178 | Jun 23, 2025 |
| Jun 20, 2025 | POpen-market purchase Common Stock | +690 | $1.42 | $980 | 64,868 | Jun 23, 2025 |
Related signals
Other insiders at Tharimmune, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 40Moderate | CNTNsell Tharimmune, Inc. | Gary S. Stetz director | $344k 100,351 shares | -43% | |
| 71Notable | Tharimmune, Inc. | Gravitas Capital LP Executive Chairman | $500k 337,838 shares | +86% | |
| 53Moderate | Tharimmune, Inc. | Sanam Parikh COO | $1,450 1,000 shares | +130% | |
| 31Weak | CNTNbuy Tharimmune, Inc. | Sanam Parikh COO | $1,001 770 shares | - | |
| 31Weak | CNTNbuy Tharimmune, Inc. | Randy Milby CEO | $9,752 4,600 shares | +36% | |
| 30Weak | CNTNbuy Tharimmune, Inc. | Sireesh Appajosyula Chief Operating Officer | $10k 5,000 shares | +87% | |
| 44Moderate | CNTNbuy Tharimmune, Inc. | Randy Milby CEO | $15k 29,000 shares | +23% | |
| 46Moderate | CNTNbuy Tharimmune, Inc. | Randy Milby CEO | $10k 10,000 shares | +9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.